Cargando…
Cytotoxicity of nimbolide towards multidrug-resistant tumor cells and hypersensitivity via cellular metabolic modulation
Nimbolide is considered a promising natural product in cancer prevention and treatment. However, it is not known yet, whether the different mechanisms of multidrug resistance (MDR) influence its anticancer activity. In this study, well-known MDR mechanisms (ABCB1, ABCG2, ABCB5, TP53, EGFR) were eval...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254660/ https://www.ncbi.nlm.nih.gov/pubmed/30515268 http://dx.doi.org/10.18632/oncotarget.26299 |
_version_ | 1783373774379286528 |
---|---|
author | Mahmoud, Nuha Saeed, Mohamed E.M. Sugimoto, Yoshikazu Klauck, Sabine M. Greten, Henry J. Efferth, Thomas |
author_facet | Mahmoud, Nuha Saeed, Mohamed E.M. Sugimoto, Yoshikazu Klauck, Sabine M. Greten, Henry J. Efferth, Thomas |
author_sort | Mahmoud, Nuha |
collection | PubMed |
description | Nimbolide is considered a promising natural product in cancer prevention and treatment. However, it is not known yet, whether the different mechanisms of multidrug resistance (MDR) influence its anticancer activity. In this study, well-known MDR mechanisms (ABCB1, ABCG2, ABCB5, TP53, EGFR) were evaluated against nimbolide. The P-glycoprotein (ABCB1/MDR1)-overexpressing CEM/ADR5000 cell line displayed remarkable hypersensitivity to nimbolide, which was mediated through upregulation of the tumor suppressor, PTEN, and its downstream components resulted in significant downregulation in ABCB1/MDR1 mRNA and P-glycoprotein. In addition, nimbolide targeted essential cellular metabolic-regulating elements including HIF1α, FoxO1, MYC and reactive oxygen species. The expression of breast cancer resistance protein (BCRP) as well as epidermal growth factor receptor (EGFR) and mutant tumor suppressor TP53 did not correlate to nimbolide’s activity. Furthermore, this paper looked for other molecular determinants that might determine tumor cellular response towards nimbolide. COMPARE and hierarchical cluster analyses of transcriptome-wide microarray-based mRNA expressions of the NCI 60 cell line panel were performed, and a set of 40 genes from different functional groups was identified. The data suggested NF-κB as master regulator of nimbolide’s activity. Interestingly, HIF1α was determined by COMPARE analysis to mediate sensitivity to nimbolide, which would be of great benefit in targeted therapy. |
format | Online Article Text |
id | pubmed-6254660 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-62546602018-12-04 Cytotoxicity of nimbolide towards multidrug-resistant tumor cells and hypersensitivity via cellular metabolic modulation Mahmoud, Nuha Saeed, Mohamed E.M. Sugimoto, Yoshikazu Klauck, Sabine M. Greten, Henry J. Efferth, Thomas Oncotarget Research Paper Nimbolide is considered a promising natural product in cancer prevention and treatment. However, it is not known yet, whether the different mechanisms of multidrug resistance (MDR) influence its anticancer activity. In this study, well-known MDR mechanisms (ABCB1, ABCG2, ABCB5, TP53, EGFR) were evaluated against nimbolide. The P-glycoprotein (ABCB1/MDR1)-overexpressing CEM/ADR5000 cell line displayed remarkable hypersensitivity to nimbolide, which was mediated through upregulation of the tumor suppressor, PTEN, and its downstream components resulted in significant downregulation in ABCB1/MDR1 mRNA and P-glycoprotein. In addition, nimbolide targeted essential cellular metabolic-regulating elements including HIF1α, FoxO1, MYC and reactive oxygen species. The expression of breast cancer resistance protein (BCRP) as well as epidermal growth factor receptor (EGFR) and mutant tumor suppressor TP53 did not correlate to nimbolide’s activity. Furthermore, this paper looked for other molecular determinants that might determine tumor cellular response towards nimbolide. COMPARE and hierarchical cluster analyses of transcriptome-wide microarray-based mRNA expressions of the NCI 60 cell line panel were performed, and a set of 40 genes from different functional groups was identified. The data suggested NF-κB as master regulator of nimbolide’s activity. Interestingly, HIF1α was determined by COMPARE analysis to mediate sensitivity to nimbolide, which would be of great benefit in targeted therapy. Impact Journals LLC 2018-11-06 /pmc/articles/PMC6254660/ /pubmed/30515268 http://dx.doi.org/10.18632/oncotarget.26299 Text en Copyright: © 2018 Mahmoud et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Mahmoud, Nuha Saeed, Mohamed E.M. Sugimoto, Yoshikazu Klauck, Sabine M. Greten, Henry J. Efferth, Thomas Cytotoxicity of nimbolide towards multidrug-resistant tumor cells and hypersensitivity via cellular metabolic modulation |
title | Cytotoxicity of nimbolide towards multidrug-resistant tumor cells and hypersensitivity via cellular metabolic modulation |
title_full | Cytotoxicity of nimbolide towards multidrug-resistant tumor cells and hypersensitivity via cellular metabolic modulation |
title_fullStr | Cytotoxicity of nimbolide towards multidrug-resistant tumor cells and hypersensitivity via cellular metabolic modulation |
title_full_unstemmed | Cytotoxicity of nimbolide towards multidrug-resistant tumor cells and hypersensitivity via cellular metabolic modulation |
title_short | Cytotoxicity of nimbolide towards multidrug-resistant tumor cells and hypersensitivity via cellular metabolic modulation |
title_sort | cytotoxicity of nimbolide towards multidrug-resistant tumor cells and hypersensitivity via cellular metabolic modulation |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254660/ https://www.ncbi.nlm.nih.gov/pubmed/30515268 http://dx.doi.org/10.18632/oncotarget.26299 |
work_keys_str_mv | AT mahmoudnuha cytotoxicityofnimbolidetowardsmultidrugresistanttumorcellsandhypersensitivityviacellularmetabolicmodulation AT saeedmohamedem cytotoxicityofnimbolidetowardsmultidrugresistanttumorcellsandhypersensitivityviacellularmetabolicmodulation AT sugimotoyoshikazu cytotoxicityofnimbolidetowardsmultidrugresistanttumorcellsandhypersensitivityviacellularmetabolicmodulation AT klaucksabinem cytotoxicityofnimbolidetowardsmultidrugresistanttumorcellsandhypersensitivityviacellularmetabolicmodulation AT gretenhenryj cytotoxicityofnimbolidetowardsmultidrugresistanttumorcellsandhypersensitivityviacellularmetabolicmodulation AT efferththomas cytotoxicityofnimbolidetowardsmultidrugresistanttumorcellsandhypersensitivityviacellularmetabolicmodulation |